Live Breaking News & Updates on Following Upcoming Virtual

Stay updated with breaking news from Following upcoming virtual. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Poxel SA: Poxel Provides Corporate Update and Reports Cash and Revenue for the Second Quarter and First Half 2021

Poxel SA: Poxel Provides Corporate Update and Reports Cash and Revenue for the Second Quarter and First Half 2021
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , South Korea , Sumitomo Dainippon Pharma , Arthur Rouill , John Kozarich , Thomas Kuhn , Valeria Fisher , Catherine David , Clinical Development Updates , Financial Press , International Nonproprietary Name , Trophic Communications , International Liver Congress , European Association , International Liver , Kenneth Cusi , Vlad Ratziu , Annual Meeting , Japan Diabetes Society , Sumitomo Dainippon , Bpifrance Participations , First Half , Imeglimin Phase , Following Upcoming Virtual , Annual Global Investment Conference September , France September ,

Poxel SA: Poxel Provides Corporate Update and Reports Cash and Revenue for the First Quarter 2021

Poxel SA: Poxel Provides Corporate Update and Reports Cash and Revenue for the First Quarter 2021
with product launch anticipated in 2021
1
Poxel regained Imeglimin rights from Metavant for US, Europe and other countries not covered by its agreement with Sumitomo Dainippon Pharma and is pursuing next steps to advance its development including partnering activities
Poxel continues to prepare for initiation of Phase 2b trial with PXL770 in patients with biopsy-proven NASH and pre-diabetes or type 2 diabetes, expected to commence in H2 2021
PXL065 Phase 2 study ongoing with completion of recruitment expected in mid-2021 and topline data readout in mid-2022
Imeglimin and PXL065 preclinical and clinical data published in peer reviewed journals; PXL770 data accepted for oral and poster presentations at an upcoming scientific conference ....

United States , South Korea , Arthur Rouill , Merck Serono , Thomas Kuhn , Sumitomo Dainippon Pharma , Valeria Fisher , Catherine David , Additional Development Opportunities , Raymond James Human Health Innovations Conference , Drug Development Summit , World Health Organization , Meeting Of The Japanese Diabetes Society , Trophic Communications , Phepatology Communications , Clinical Development Updates , Kempen Life Sciences Conference , Devices Agency , Financial Press , Imeglimin Japanese New Drug Application , Medical Devices Agency , Fiscal Year , Sumitomo Dainippon , European Association , Pioglitazone Efficacy , Exhibits Little ,

Poxel Provides Corporate Update and Reports Cash and Revenue for the First Quarter 2021

Poxel Provides Corporate Update and Reports Cash and Revenue for the First Quarter 2021
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

United States , South Korea , Arthur Rouill , Merck Serono , Thomas Kuhn , Sumitomo Dainippon Pharma , Valeria Fisher , Catherine David , Additional Development Opportunities , Raymond James Human Health Innovations Conference , Drug Development Summit , World Health Organization , Meeting Of The Japanese Diabetes Society , Trophic Communications , Phepatology Communications , Clinical Development Updates , Kempen Life Sciences Conference , Devices Agency , Financial Press , Poxel Provides Corporate Update , Reports Cash , First Quarter , Japanese New Drug Application , Medical Devices Agency , Fiscal Year , Sumitomo Dainippon ,